Epigenetic Reprogramming in Atherosclerosis
Epigenetic Reprogramming in Atherosclerosis
批准号:
9914292
负责人:
MICHAEL Leo FITZGERALD
金额:
$67.36万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-07-01 至 2022-04-30
关键词:
Anti-Inflammatory AgentsApolipoprotein EArterial Fatty StreakArterial IntimasAtherosclerosisAutoimmune DiseasesBone MarrowCellsCessation of lifeChIP-seqChemicalsCholesterolChronicCoronary heart diseaseCrystallizationCytoplasmic ProteinDataDepositionDietEnzyme Inhibitor DrugsEnzyme TestsEpigenetic ProcessFatty acid glycerol estersGene Expression ProfilingGenetic ModelsGenetic TranscriptionGoutHIVHealth BenefitHigh Density Lipoprotein CholesterolHigh Density LipoproteinsHistonesImmuneImmune responseImmune signalingImmunityImmunologic MemoryImmunologic TestsInflammasomeInflammatoryInterleukin-1 betaLeadLipidsLow-Density LipoproteinsMediatingMorbidity - disease rateMusMyelogenousMyeloid Progenitor CellsNatureOutcome StudyPathologicPhagocytesPlasmaPublic HealthPublishingRheumatoid ArthritisRiskSerumSignal TransductionStimulusSystemic Lupus ErythematosusTestingTimeTissuesTrainingTranscription RepressorViremiaXCL1 geneactivating transcription factor 3cardiovascular disorder riskchromatin remodelingcoronary artery occlusioncytokinedisorder riskfeedinggranulocyte-monocyte progenitorshistone modificationhypercholesterolemialow income countrymacrophagemicrobialmonocytemortalitymouse modelnew therapeutic targetnovelpatient populationpressureprogenitorprotein complexrecruitresponsestem cellstranscriptome sequencingwestern diet
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
Epigenetic Reprogramming in Atherosclerosis: Occlusion of coronary arteries by atherosclerotic plaque is
the leading cause of mortality and morbidity in the developed world, and is rapidly becoming so in lower
income countries, with an estimated 7.4 million deaths globally due to coronary heart disease. Inappropriate
lipid deposition in the sub-endothelial arterial space drives plaque progression by the recruitment and
differentiation of immune cells, principally monocyte-derived macrophages who attempt to phagocytose these
pathologic lipid deposits. Lipid deposition and disease risk is positively correlated with circulating levels of
cholesterol carried by low density lipoprotein (LDL). Conversely, higher serum levels of high density lipoprotein
(HDL) cholesterol and function associate with decreased risk.
We have shown that as LDL derived lipids accumulate and crystallize in the sub-endothelial space and this
triggers activation of a large cytoplasmic protein complex termed the NLRP3 inflammasome. This activation
triggers subsequent processing and secretion of pro-inflammatory cytokines including IL-1β, that in a feed
forward mechanism, recruits more immune cells to the developing plaque. Conversely, and more recently, we
have discovered HDL triggers the activity of an anti-inflammatory transcriptional repressor termed ATF3.
Most interestingly, we have now also found that Western diet feeding imparts a long-lived immune hyper-
responsiveness of bone marrow myeloid progenitors and tissue resident macrophages. Transcriptional profiling
using RNA sequencing identified that Western diet feeding induces a primed and hyper-inflammatory state of
granulocyte / monocyte progenitors (GMPs) leading to their exacerbated responsiveness towards innate
immune activators and their increased proliferation and activation in the bone marrow.
In aggregate, our published and preliminary data suggests a hypothesis positing that the pathologic deposition
of LDL derived lipid triggers signaling and transcriptional responses that are long lived and are, in part,
encoded by an epigenetic reprogramming mechanism in macrophage progenitors and tissue resident
macrophages. To explore this hypothesis we propose three specific aims: Aim-1: Define the nature of the long-
lived inflammatory signal imparted by the pressure of dietary LDL hypercholesterolemia on macrophage
progenitor cells as well as plaque macrophages in mouse models of atherosclerosis. Aim-2: Define if the long-
lived hyper-immune state of macrophages is encoded by an epigenetic mechanism and influenced by NLRP3
inflammasome activation. Aim-3: To identify how Western diet induces transcriptional and epigenetic
reprogramming of cells.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Epigenetic Reprogramming in Atherosclerosis
-
批准号:9382567
-
项目类别:
-
资助金额:$69.05万
-
财政年份:2017
-
负责人:MICHAEL Leo FITZGERALD
-
依托单位:
HDL prevention of cholesterol crystal inflammation in HIV disease
-
批准号:8884627
-
项目类别:
-
资助金额:$60.29万
-
财政年份:2012
-
负责人:MICHAEL Leo FITZGERALD
-
依托单位:
HDL prevention of cholesterol crystal inflammation in HIV disease
-
批准号:8221304
-
项目类别:
-
资助金额:$64.68万
-
财政年份:2012
-
负责人:MICHAEL Leo FITZGERALD
-
依托单位:
HDL prevention of cholesterol crystal inflammation in HIV disease
-
批准号:8551689
-
项目类别:
-
资助金额:$59.34万
-
财政年份:2012
-
负责人:MICHAEL Leo FITZGERALD
-
依托单位:
HDL prevention of cholesterol crystal inflammation in HIV disease
-
批准号:9098831
-
项目类别:
-
资助金额:$60.58万
-
财政年份:2012
-
负责人:MICHAEL Leo FITZGERALD
-
依托单位:
ABCA1 cholesterol efflux & protein-protein interactions
-
批准号:7105050
-
项目类别:
-
资助金额:$38.45万
-
财政年份:2005
-
负责人:MICHAEL Leo FITZGERALD
-
依托单位:
ABCA1 cholesterol efflux & protein-protein interactions
-
批准号:7267835
-
项目类别:
-
资助金额:$37.33万
-
财政年份:2005
-
负责人:MICHAEL Leo FITZGERALD
-
依托单位:
ABCA1 cholesterol efflux & protein-protein interactions
-
批准号:6922977
-
项目类别:
-
资助金额:$41.48万
-
财政年份:2005
-
负责人:MICHAEL Leo FITZGERALD
-
依托单位:
ABCA1 cholesterol efflux & protein-protein interactions
-
批准号:7480213
-
项目类别:
-
资助金额:$37.33万
-
财政年份:2005
-
负责人:MICHAEL Leo FITZGERALD
-
依托单位:
FUNCTIONAL ANALYSIS OF THE TANGIER DISEASE GENE ABC1
-
批准号:6402737
-
项目类别:
-
资助金额:$4.94万
-
财政年份:2001
-
负责人:MICHAEL Leo FITZGERALD
-
依托单位:
FUNCTIONAL ANALYSIS OF THE TANGIER DISEASE GENE ABC1
-
批准号:6208198
-
项目类别:
-
资助金额:$4.43万
-
财政年份:2000
-
负责人:MICHAEL Leo FITZGERALD
-
依托单位:
海外基金